These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11892937)

  • 21. Delayed treatment with 5-nitro-6,7-dichloro-1,4-dihydro-2,3-quinoxalinedione, a glycine site N-methyl-D-aspartate antagonist, protects against permanent middle cerebral artery occlusion in male rats.
    Sarhan S; Wettstein JG; Maynard KI
    Neurosci Lett; 2003 Aug; 347(3):147-50. PubMed ID: 12875907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice.
    Li J; Henman MC; Doyle KM; Strbian D; Kirby BP; Tatlisumak T; Shaw GG
    Brain Res; 2004 Dec; 1029(1):84-92. PubMed ID: 15533319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity.
    Dong CJ; Guo Y; Agey P; Wheeler L; Hare WA
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4515-22. PubMed ID: 18566471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CoMFA, synthesis, and pharmacological evaluation of (E)-3-(2-carboxy-2-arylvinyl)-4,6-dichloro-1H-indole-2-carboxylic acids: 3-[2-(3-aminophenyl)-2-carboxyvinyl]-4,6-dichloro-1H-indole-2-carboxylic acid, a potent selective glycine-site NMDA receptor antagonist.
    Baron BM; Cregge RJ; Farr RA; Friedrich D; Gross RS; Harrison BL; Janowick DA; Matthews D; McCloskey TC; Meikrantz S; Nyce PL; Vaz R; Metz WA
    J Med Chem; 2005 Feb; 48(4):995-1018. PubMed ID: 15715469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paradigm shift in neuroprotective drug development: clinically tolerated NMDA receptor inhibition by memantine.
    Lipton SA; Chen HS
    Cell Death Differ; 2004 Jan; 11(1):18-20. PubMed ID: 14647237
    [No Abstract]   [Full Text] [Related]  

  • 26. Desensitization of NMDA receptors as a mechanism of neuroprotection.
    Villarroel A; Regalado MP; Lerma J
    Methods Find Exp Clin Pharmacol; 1997; 19 Suppl A():51-3. PubMed ID: 9403858
    [No Abstract]   [Full Text] [Related]  

  • 27. Nicaraven Chugai.
    Leker RR
    Curr Opin Investig Drugs; 2003 Jan; 4(1):83-90. PubMed ID: 12625035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of glycine receptors and glycine release for the neuroprotective activity of bilobalide.
    Kiewert C; Kumar V; Hildmann O; Hartmann J; Hillert M; Klein J
    Brain Res; 2008 Mar; 1201():143-50. PubMed ID: 18325484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The NMDA receptor complex: a long and winding road to therapeutics.
    Wood PL
    IDrugs; 2005 Mar; 8(3):229-35. PubMed ID: 15772895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro galantamine-memantine co-application: mechanism of beneficial action.
    Zhao X; Marszalec W; Toth PT; Huang J; Yeh JZ; Narahashi T
    Neuropharmacology; 2006 Dec; 51(7-8):1181-91. PubMed ID: 17011596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel glycine site-specific N-methyl-D-aspartate receptor antagonist prevents activation of the NMDA/NO/CGMP pathway by ammonia.
    Hilgier W; Oja SS; Saransaari P; Albrecht J
    Brain Res; 2004 Jul; 1015(1-2):186-8. PubMed ID: 15223384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Taurine potentiates presynaptic NMDA receptors in hippocampal Schaffer collateral axons.
    Suárez LM; Solís JM
    Eur J Neurosci; 2006 Jul; 24(2):405-18. PubMed ID: 16836643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential neuroprotective effects of the NMDA receptor-associated glycine site partial agonists 1-aminocyclopropanecarboxylic acid (ACPC) and D-cycloserine in lithium-pilocarpine status epilepticus.
    Peterson SL; Purvis RS; Griffith JW
    Neurotoxicology; 2004 Sep; 25(5):835-47. PubMed ID: 15288514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutically relevant plasma concentrations of memantine produce significant L-N-methyl-D-aspartate receptor occupation and do not impair learning in rats.
    Morè L; Gravius A; Nagel J; Valastro B; Greco S; Danysz W
    Behav Pharmacol; 2008 Oct; 19(7):724-34. PubMed ID: 18797249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotective effects of a selective N-methyl-D-aspartate NR2B receptor antagonist in the 6-hydroxydopamine rat model of Parkinson's disease.
    Leaver KR; Allbutt HN; Creber NJ; Kassiou M; Henderson JM
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1388-94. PubMed ID: 18785982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel pyrrolinones as N-methyl-D-aspartate receptor antagonists.
    Poschenrieder H; Stachel HD; Höfner G; Mayer P
    Eur J Med Chem; 2005 Apr; 40(4):391-400. PubMed ID: 15804538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of analogues of 7-chloro-4,5-dihydro-4- oxo-8-(1,2,4-triazol-4-yl)-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylic acid (TQX-173) as novel selective AMPA receptor antagonists.
    Catarzi D; Colotta V; Varano F; Calabri FR; Filacchioni G; Galli A; Costagli C; Carlà V
    J Med Chem; 2004 Jan; 47(1):262-72. PubMed ID: 14695840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
    Frizelle PA; Chen PE; Wyllie DJ
    Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of acute ischaemic stroke with the low-affinity, use-dependent NMDA antagonist AR-R15896AR. A safety and tolerability study.
    Diener HC; AlKhedr A; Busse O; Hacke W; Zingmark PH; Jonsson N; Basun H;
    J Neurol; 2002 May; 249(5):561-8. PubMed ID: 12021946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re-evaluation of phencyclidine low-affinity or "non-NMDA" binding sites.
    Hirbec H; Mausset AL; Kamenka JM; Privat A; Vignon J
    J Neurosci Res; 2002 May; 68(3):305-14. PubMed ID: 12111860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.